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1. Introduction 
It is shown that puromycin (fig. 1A) reacts on the 
ribosome with peptidyl-tRNA as the acceptor of the 
peptidyl residue (i.e., as aminoacyl-t RNA) [ 1 ] . Along 
with puromycin some 2’(3’)&minoacyl adenosines 
[2] and 2’,3’-O-bis-aminoacyl adenosines (fig. 1B) 
[3] can act as acceptors. It is also known that 
3’-O-phenylalanyl-2’-deoxyadenosine has almost no 
such activity [4]. 
In the present paper 3’-U-phenylalanyl-2’-O- 
methyladenosine (fig. lC), synthesized by us, was 
used as an acceptor in the peptidyl-transferase reac- 
tion, and it is shown that this compound possesses a
significant acceptor activity close to that of puro- 
mycin . 
2. Materials and methods 
2.1.3’~0phenylalanyl-2’-O-methyladenosine 
2’-O-Methyladenosine was prepared by methylating 
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Fig. 1. A: Puromycin; B: 2’,3’-Ibis-aminoacyl adenosine; C: 3%phenylalanyl-2’-Omethyladenosine. 
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Table 1 
Transfer of AcPhe from AcPhetRNA to 3’-0phenylalanyl-2’Gmethyladenosine in ribosomes with polyU. 
Conditions of experiment 
Transfer of AcPhe 
PoluU-stimu- from AcPhe-tRNA to Effectiveness of Binding of 
lated binding puromycin 013’-O- 3’-OphenyIalanyl- AcPhe-tRNA 
of AcPhe-tRNA 
2’-O-methyl- 
with ribo- phenylalanyl-2’~O- 
with rrbosomes methyladenosine adenosine relative 
somes (cpm) 
(cpm) ---_ to puromycin 
(cpm) (%) (%) 
AcPhe-tRNA + ribosomes + PolyU 
AcPhe-tRNA + ribosomes 
4160 3300 - - 
860 - - 
AcPhe-tRNA + ribosomes + polyU + 
puromycin (10m3 M) 
AcPhe-tRNA + ribosomes + polyU + 
puromycin (5 x 10m4 M) 
2160 1300 2000 61 
68 
AcPhe-tRNA + ribosomes + polyU + 
3’-0-phenykdanyl-2’-O-methyl- 
adenosine (10m3 M) 
2120 1260 2040 62 91 
AcPhe-tRNA + ribosomes + polyU + 
3’-O-phenylalanyl-2’-Omethyl- 
adenosine (5 X lo4 M) 
2600 1740 1560 47.5 78 
Conditions of experiment: 
Incubation mixture: AcPhe-tRNA, 10 100 cpm; 2.8 Aa60 units of ribosomes, 0.8 Aaeo units of polyU; buffer: 5 X 10” M 
triethanolaminc, 0.015 M MgCl2, 0.16 M NH&l, pH 7.2. Total volume of mixture, 0.1 mI. Incubation time, 20 min, tempera- 
ture, 30’. Incubation was stopped by adding 2 ml of cold buffer, filtering through nitrocellulose filters HUFS or VUFS (Chema- 
pol, Czechoslovakia) and washing with 25 ml of the same buffer. 
Table 2 
Transfer of AcPhe from AcPhetRNA to 3’-Ophenylalanine-2’-O-methyladenosine in ribosomes not containing templates. 
Transfer of AcPhe from Effectiveness of 
Conditions of experiment 
Radioactivity in 
ethyl acetate 
(cpm) 
AcPhetRNA to puromycin 
or 3’-0phenylalanyl-2’-O- 
methyladenosine 
(cpm) (%) 
3’Gphenylalanyl- 
2’Gmethyladeno- 
sine relative to 
puromycin 
(%) 
AcPhe-tRNA + ribosomes 830 - - - 
AcPhetRNA + ribosomes + puromycin 
(1O-3 M) 
AcPhe-tRNA + ribosomes + puromycin 
(lo4 M) 
2240 1410 31.0 - 
1720 890 19.5 - 
AcPhe-tRNA + ribosomes + 3’Gphenylalanyl 
2’-O-methyladenosine (10m3 M) 
1340 510 11.2 36 
AcPhe-tRNA + ribosomes + 3’-Ophenylalanyl- 
2’-O-methyladenosine (10e4 M) 
1200 370 8.1 41.5 
Conditions of experiment: 
Incubation mixture: AcPhe-tRNA, 5400 cpm; 3 Aaeo units of ribosomes; buffer: 0.4 M KCl, 0.05 M TrisHCl, 0.01 M MgCl2, 
pH 7.5; ethyl alcohol, 33%. Total volume of mixture, 0.3 ml. Incubation time, 4 hr, temperature, 24”. Incubation was stopped 
by adding 0.7 ml of buffer containing 0.01 M Tris-HCl, pH 7.0 and 3 ml of ethylacetate. After mixing, 2 ml of the organic 
layer was taken and its radioactivity measured in a scintillating liquid described by Prockop [ 121, 
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adenosine with diazomethane in the presence of stan- 
nit chloride [5] .3’-O-Phenylalanyl-2’-O-methyladeno- 
sine was obtained in the same way as in the synthesis 
of 2’(3’)0-phenylalanyladenosine [6 3 proceeding from 
5’-0-trityl-2’-0-methyladenosine and tert-butyl-oxy- 
carbonylphenylalanine anhydride. Protecting groups 
were removed by trifluoroacetic acid. 
2.2. Testing of peptide-acceptor activity 
E. coli B tRNA enriched with the phenylalanyl- 
acceptor fraction [7] and containing 18% tRNA was 
used in the study. [“Cl Phe-tRNA was prepared by 
the known method [8] (the labelled [‘“Cl phenyl- 
alanine used had a specific radioactivity of 220 
&i/mmole and was supplied by &WR, Czecho- 
slovakia). AC-[14C] Phe-tRNA was synthesized from 
[“Cl Phe-tRNA and acetyloxysuccinimide by the 
method of Lapidot et al. [9]. Radioactivity of the 
preparations was measured in the SL-40 Liquid Scin- 
tillation Spectrometer (Intertechnique, France). 
Testing of the 3’-0-phenylalanyl-2’-O-methyl- 
adenosine peptide-acceptor activity was performed in 
a system containing “charged” AC- [ 14C] Phe-tRNA 
E. coli B ribosomes both in the presence of the poly U 
[4] and in a template-free system in the presence of 
alcohol (according to [IO] ). In both cases the amount 
of acetyl-phenylalanine carried over from the 
AC- [ 14C] Phe-tRNA to the 3’-O-phenylalanyl-2’-O- 
methyladenosine served as the measure of activity 
(puromycin-like effect). 
3. Results and discussion 
Data is presented in table 1 and 2 showing that 
3’-0-phenylalanyl-2’-0-methyladenosine possesses a
noticeable peptide-acceptor activity which in a num- 
ber of cases is comparable with puromycin activity. 
Needless to say a more precise and complete com- 
parison can be made by investigating the kinetics of 
the process. Such studies are being carried out and the 
results will shortly be published. 
In order directly to confirm the mechanism of 
action of 3’-O-phenylalanyl-2’-0-methyladenosine, a
comparison of the reaction product formed on the 
ribosomes with the synthetically obtained material 
was made. Judging by electrophoretic mobility, both 
substances proved to be identical. 
The fact that 3’-0-phenylalanyl-2’-O-methyl- 
adenosine appeared to be a good peptide acceptor 
permits one critically to evaluate the hypothesis of 
H. Neuman et al. [l l] on the two-step mechanism 
of peptide bond synthesis in the ribosome. According 
to this hypothesis the peptide residue with the 
peptidyl-tRNA is carried over to the free hydroxyl 
of the aminaacyl-tRNA terminal adenosine at the 
first step of reaction. The second step, the formation 
of the peptide bond proper is, in essence, already an 
intramolecular reaction. 
Data reported in the literature on the activity of 
different model compounds utilized as a peptide 
acceptor in ribosomes do not allow one to come to 
any unambiguous conclusion. For example it is known 
that 3’-0-phenylalanyl-2’-deoxyadenosine has almost 
no acceptor activity [4] which is evidence in favor of 
the hypothesis. On the other hand 2’,3’-O-L-bis-phenyl- 
alanyladenosine is an effective enough peptide 
acceptor [3] and this can be considered as a contra- 
diction of the hypothesis. In this sense 3’-O-phenyl- 
alanyl-2’-O-methyladenosine is a convenient model for 
testing the hypothesis. 
The results obtained by us provide evidence that 
during peptide bond synthesis in the ribosome, the 
2’-oxygroup of the peptide acceptor molecule does 
not play the very essential role that is assigned to it 
in H. Neuman’s hypothesis [ 1 l] . Of course, this fact 
does not mean that the 2’-oxygroup in the peptide 
donor molecule does not also have some functional 
meaning in the catalysis of the peptidyl-transferase 
reaction. The role of this oxygroup remains to be 
elucidated by further experiments. 
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